|
2023
|
Invention
|
Peptide conjugates.
Methods and compositions related to the selective, specific disruption of mu... |
|
2022
|
Invention
|
Selective peptide antagonists.
Methods and compositions related to the selective, specific disru... |
|
|
Invention
|
Modulating gamma-c-cytokine activity.
Embodiments relate to peptide antagonists of γc-family cyt... |
|
2021
|
Invention
|
Antagonistic peptide targeting il-2, il-9, and il-15 signaling for the treatment of cytokinerelea... |
|
|
Invention
|
Antagonistic peptide targeting il-2, il-9, and il-15 signaling for the treatment of cytokine-rele... |
|
2020
|
Invention
|
Selective peptide antagonists. Methods and compositions related to the selective, specific disrup... |
|
|
Invention
|
Peptide conjugates. Methods and compositions related to the selective, specific disruption of mul... |
|
|
Invention
|
Modulating the effects of gamma-c-cytokine signaling for the treatment of alopecia and alopecia a... |
|
2018
|
Invention
|
Stable modulators of gamma-c-cytokine activity.
Disclosed herein are stable peptide antagonists ... |
|
|
Invention
|
Stable modulators of gamma-c-cytokine activity. Disclosed herein are stable peptide antagonists b... |
|
2016
|
Invention
|
Modulating gamma-c-cytokine activity. Embodiments relate to peptide antagonists of γc-family cyto... |
|
|
Invention
|
Modulating gamma - c -cytokine activity. Embodiments relate to peptide antagonists of ƴc-farnily ... |
|
|
Invention
|
Methods of developing selective peptide antagonists. Methods and compositions related to the sele... |
|
2012
|
Invention
|
Compositions and mehthods for modulating gamma-c-cytokine activity. The vanous embodiments relate... |
